hotspot -WSS

hotspot

author：comprehensive 2025-08-04 05:20:12 Page View：83137

Terry Horgan pictured at home -- coverage from STAT — Terry Horgan in his family's Montour Falls, N.Y., home, in an undated photo. Kate Collins/The Journal via AP

Last October, a 27-year-old man with Duchenne muscular dystrophy died after receiving a CRISPR-based treatment custom built to treat his particular genetic mutation.

Results of a detailed investigation released on Wednesday suggest that the patient, Terry Horgan, likely died of a previously undocumented adverse effect of the virus used to deliver the CRISPR machinery to his cells.

These viruses, known as adeno-associated viruses, or AAVs, are used in several approved drugs and hundreds of clinical trials to deliver genes into patients, because they are generally benign. But at high doses they can cause side effects and, occasionally, deaths through one of several mechanisms, such as directly injuring the liver or triggering a type of immune response known as complement activation.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： FDA rejects Alnylam's heart disease treatment over insufficient data
Next article： Apple is now the first public company to be valued at $3 trillion

explore

Duchenne breakthrough therapy leaves behind pioneering families

DuchennemusculardystrophyDr.EdwinP.Ewing,Jr./CDCPatFurlongwassittinginherhomeofficeinMiddletown,Ohio

Sana to lay off nearly a third of staff, de

Illustrationofatealcancercell.AdobeSanaBiotechnology,astartupthatjustacoupleofyearsagoraisedover$1bi

At least 13 dead in Texas as scorching temps continue

1:17FirefighterEMTWilliamDorseyandfirefighterEMTRodrigoPinedatreatamigrantwomansufferingfromheatexha

What would happen to your eyes if you looked at the solar eclipse?

PeopleacrosstheU.S.willbeabletowatchMonday'ssolareclipse—butcanwatchingitwithoutanyeyeprotectionhurt